Bullock, J.L., Jr.; Hickey, T.E.; Kemp, T.J.; Metz, J.; Loftus, S.; Haynesworth, K.; Castro, N.; Luke, B.T.; Lowy, D.R.; Pinto, L.A.
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination. Vaccines 2024, 12, 516.
https://doi.org/10.3390/vaccines12050516
AMA Style
Bullock JL Jr., Hickey TE, Kemp TJ, Metz J, Loftus S, Haynesworth K, Castro N, Luke BT, Lowy DR, Pinto LA.
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination. Vaccines. 2024; 12(5):516.
https://doi.org/10.3390/vaccines12050516
Chicago/Turabian Style
Bullock, Jimmie L., Jr., Thomas E. Hickey, Troy J. Kemp, Jordan Metz, Sarah Loftus, Katarzyna Haynesworth, Nicholas Castro, Brian T. Luke, Douglas R. Lowy, and Ligia A. Pinto.
2024. "Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination" Vaccines 12, no. 5: 516.
https://doi.org/10.3390/vaccines12050516
APA Style
Bullock, J. L., Jr., Hickey, T. E., Kemp, T. J., Metz, J., Loftus, S., Haynesworth, K., Castro, N., Luke, B. T., Lowy, D. R., & Pinto, L. A.
(2024). Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination. Vaccines, 12(5), 516.
https://doi.org/10.3390/vaccines12050516
